BTIG Keeps Buy Ratings on Five Companies, Updates Targets
BTIG maintained Buy ratings on DexCom, Carlsmed, Avita Medical, Medtronic and Onity Group, while changing price targets for three of the stocks.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Dow Jones Newswires, citing ratings actions from Benzinga, reported on October 12, 2026 that BTIG maintained a Buy rating on shares of DexCom, Carlsmed, Avita Medical, Medtronic and Onity Group.
BTIG raised DexCom’s price target to $96.00 per share from $90.00. The target for Medtronic was cut to $99.00 from $100.00, while Onity Group’s target was lowered to $45.00 from $50.00 per share.
No price-target changes were specified in the reports on Carlsmed or Avita Medical. Benzinga was identified as the source of the ratings actions.
why it matters
The unchanged Buy ratings alongside mixed target-price revisions indicate that BTIG updated its company-level valuations without changing its overall stance on the five stocks. DexCom received an upward revision, while targets for Medtronic and Onity Group were reduced.
instruments
sources
- DexCom Is Maintained at Buy by BTIG — Dow Jones Newswires, 12 October 2026 at 10:07 UTC
- Carlsmed Is Maintained at Buy by BTIG — Dow Jones Newswires, 12 October 2026 at 10:06 UTC
- Avita Medical Is Maintained at Buy by BTIG — Dow Jones Newswires, 12 October 2026 at 10:05 UTC
- Medtronic Is Maintained at Buy by BTIG — Dow Jones Newswires, 12 October 2026 at 10:18 UTC
- Onity Group Is Maintained at Buy by BTIG — Dow Jones Newswires, 12 October 2026 at 10:32 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗